The Walden Group is pleased to provide access to its Q3 2021 Strategic Healthcare M&A Report, which includes:
Market Overview
Major M&A Deals by Sector
What the CEOs are Saying
Selected Recent Healthcare IPOs
Key Stats on Top M&A Deals in 2021
Performance of Leading Healthcare Companies
...
Read More
Hologic, Inc., a $3.8b producer of diagnostics, imaging systems and surgical products for women's health, has acquired Bolder Surgical, LLC, a developer of advanced energy vessel sealing surgical devices. The deal adds a differentiated portfolio of advanced vessel sealing and dissection tools used in laparoscopic procedures. To date, Bolder has...
Read More
Boston Scientific Corporation (NYSE: BSX; “BSX“), a $10b producer of interventional technologies for general surgery, neurosurgery, and cardiovascular health has announced the acquisition of Devoro Medical, a developer of a blood clot retrieval and removal system for arterial and venous systems. BSX has been a minority investor in Devoro...
Read More
Stryker Corporation, a $14.4b medical technology company focused on orthopedics, neurotechnology and spine, acquired Gauss Surgical, a developer of artificial intelligence-enabled technology for real-time monitoring of blood loss during surgery. Gauss Surgical’s Triton system leverages a computer vision app and iPhone to measure a patient’s...
Read More
Abbott Laboratories (NYSE: ABT), a $35b global producer of diagnostics, devices, generic pharmaceuticals and nutritional products, has acquired Walk Vascular, LLC, a developer of a commercialized thrombectomy system used to remove peripheral blood clots (JETi system). The JETi system works by inserting a distal catheter into veins and arteries...
Read More